b)

Posterna för indexnumren 006-035-00-8, 029-002-00-X, 602-020-00-0, 602-033-00-1, 603-055-00-4, 604-030-00-0, 604-092-00-9, 605-013-00-0, 605-022-00-X, 606-014-00-9, 606-021-00-7, 607-056-00-0, 607-059-00-7, 607-157-00-X, 607-172-00-1, 607-375-00-5, 607-623-00-2, 613-166-00-X, 613-121-00-4, 616-011-00-4, 616-037-00-6 och 616-207-00-X ska ersättas med följande poster: Index nr Internationell kemikalieidentifiering EG-nr CAS-nr Klassificering Märkning Specifika koncentrations gränser, M-faktorer Anm. Faroklass och kategorikod(er) Faroangivelse Kod(er) Faropiktogram, Signalord Kod(er) Faroangivelse Kod(er) Kompl. faroangivelse Kod(er) ”006-035-00-8 pirimikarb (ISO); 2-(dimetylamino)-5,6-dimetylpyrimidin-4-yl-dimetylkarbamat 245-430-1 23103-98-2 Carc. 2 Acute Tox. 3 Acute Tox. 3 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 H351 H331 H301 H317 H400 H410 GHS08 GHS06 GHS09 Dgr (Fara) H351 H331 H301 H317 H410 M = 10 M = 100” ”029-002-00-X dikopparoxid koppar(I)oxid 215-270-7 1317-39-1 Acute Tox. 4 Acute Tox. 4 Eye Dam. 1 Aquatic Acute 1 Aquatic Chronic 1 H332 H302 H318 H400 H410 GHS07 GHS05 GHS09 Dgr (Fara) H332 H302 H318 H410 M = 100” ”602-020-00-0 1,2-diklorpropan; propylendiklorid 201-152-2 78-87-5 Flam. Liq. 2 Carc. 1B Acute Tox. 4* Acute Tox. 4* H225 H350 H332 H302 GHS02 GHS08 GHS07 Dgr (Fara) H225 H350 H332 H302” ”602-033-00-1 klorbensen 203-628-5 108-90-7 Flam. Liq. 3 Acute Tox. 4 Skin Irrit. 2 Aquatic Chronic 2 H226 H332 H315 H411 GHS02 GHS07 GHS09 Wng (Varning) H226 H332 H315 H411” ”603-055-00-4 propylenoxid; 1,2-epoxipropan; metyloxiran 200-879-2 75-56-9 Flam. Liq. 1 Carc. 1B Muta. 1B Acute Tox. 3 Acute Tox. 3 Acute Tox. 4 STOT SE 3 Eye Irrit. 2 H224 H350 H340 H331 H311 H302 H335 H319 GHS02 GHS08 GHS06 Dgr (Fara) H224 H350 H340 H331 H311 H302 H335 H319” ”604-030-00-0 bisfenol A; 4,4′-isopropylidendifenol 201-245-8 80-05-7 Repr. 1B STOT SE 3 Eye Dam. 1 Skin Sens. 1 H360F H335 H318 H317 GHS08 GHS05 GHS07 Dgr (Fara) H360F H335 H318 H317” ”604-092-00-9 dodecylfenol, (grenade); [1] 2-dodecylfenol, (grenade); [2] 3-dodecylfenol, (grenade); [3] 4-dodecylfenol, (grenade); [4] fenol, (tetrapropenyl) derivat [5] 310-154-3 [1] [2] [3] [4] [5] 121158-58-5 [1] [2] [3] 210555-94-5 [4] 74499-35-7 [5] Repr. 1B Skin Corr. 1C Eye Dam. 1 Aquatic Acute 1 Aquatic Chronic 1 H360F H314 H318 H400 H410 GHS08 GHS05 GHS09 Dgr (Fara) H360F H314 H410 M = 10 M = 10” ”605-013-00-0 kloralos (INN); (R)-1,2-O-(2,2,2-trikloretyliden)-α-D-glukofuranos; glukokloralos; anhydroglukokloral 240-016-7 15879-93-3 Acute Tox. 4* Acute Tox. 3 STOT SE 3 Aquatic Acute 1 Aquatic Chronic 1 H332 H301 H336 H400 H410 GHS06 GHS09 Dgr (Fara) H332 H301 H336 H410 M = 10 M = 10 C” ”605-022-00-X glutaral; glutaraldehyd; 1,5-pentandial 203-856-5 111-30-8 Acute Tox. 2 Acute Tox. 3 STOT SE 3 Skin Corr. 1B Resp. Sens. 1 Skin Sens. 1A Aquatic Acute 1 Aquatic Chronic 2 H330 H301 H335 H314 H334 H317 H400 H411 GHS06 GHS05 GHS08 GHS09 Dgr (Fara) H330 H301 H335 H314 H334 H317 H410 EUH071 STOT SE 3; H335 0,5 % ≤ C < 5 % M = 1” ”606-014-00-9 klorfacinon (ISO); 2-[(4-klorfenyl)(fenyl)acetyl]-1H-inden-1,3(2H)-dion 223-003-0 3691-35-8 Repr. 1B Acute Tox. 1 Acute Tox. 1 Acute Tox. 1 STOT RE 1 Aquatic Acute 1 Aquatic Chronic 1 H360D H330 H310 H300 H372 (blod) H400 H410 GHS08 GHS06 GHS09 Dgr (Fara) H360D H330 H310 H300 H372 (blod) H410 Repr. 1B; H360D: C ≥ 0,003 % STOT RE 1; H372 (blod): C ≥ 0,1 % STOT RE 2; H373 (blod): 0,01 % ≤ C < 0,1 % M = 1 M = 1” ”606-021-00-7 N-metyl-2-pyrrolidon; 1-metyl-2-pyrrolidon 212-828-1 872-50-4 Repr. 1B STOT SE 3 Skin Irrit. 2 Eye Irrit. 2 H360D*** H335 H315 H319 GHS08 GHS07 Dgr (Fara) H360D*** H335 H315 H319 STOT SE 3; H335 C ≥ 10 %” ”607-056-00-0 warfarin (ISO); 4-hydroxi-3-(3-oxo-1-fenylbutyl)-2H-kromen-2-on; [1] (S)-4-hydroxi-3-(3-oxo-1-fenylbutyl)-2-bensopyron; [2] (R)-4-hydroxi-3-(3-oxo-1-fenylbutyl)-2-bensopyron [3] 201-377-6 [1] 226-907-3 [2] 226-908-9 [3] 81-81-2 [1] 5543-57-7 [2] 5543-58-8 [3] Repr. 1A Acute Tox. 1 Acute Tox. 1 Acute Tox. 2 STOT RE 1 Aquatic Chronic 2 H360D H330 H310 H300 H372 (blod) H411 GHS08 GHS06 GHS09 Dgr (Fara) H360D H330 H310 H300 H372 (blod) H411 Repr. 1A; H360D: C ≥ 0,003 % STOT RE 1; H372 (blod): C ≥ 0,5 % STOT RE 2; H373 (blod): 0,05 % ≤ C < 0,5 %” ”607-059-00-7 kumatetralyl (ISO); 4-hydroxi-3-(1,2,3,4-tetrahydro-1-naftyl]kumarin 227-424-0 5836-29-3 Repr. 1B Acute Tox. 2 Acute Tox. 3 Acute Tox. 2 STOT RE 1 Aquatic Chronic 1 H360D H330 H311 H300 H372 (blod) H410 GHS08 GHS06 GHS09 Dgr (Fara) H360D H330 H311 H300 H372 (blod) H410 Repr. 1B; H360D: C ≥ 0,003 % STOT RE 1; H372 (blod): C ≥ 1,0 % STOT RE 2; H373 (blod) 0,1 % ≤ C < 1,0 % M = 10” ”607-157-00-X difenakum (ISO); 3-(3-bifenyl-4-yl-1,2,3,4-tetrahydro-1-naftyl)-4-hydroxikumarin 259-978-4 56073-07-5 Repr. 1B Acute Tox. 1 Acute Tox. 1 Acute Tox. 1 STOT RE 1 Aquatic Acute 1 Aquatic Chronic 1 H360D H330 H310 H300 H372 (blod) H400 H410 GHS08 GHS06 GHS09 Dgr (Fara) H360D H330 H310 H300 H372 (blod) H410 Repr. 1B; H360D: C ≥ 0,003 % STOT RE 1; H372 (blod): C ≥ 0,02 % STOT RE 2; H373 (blod): 0,002 % ≤ C < 0,02 % M = 10 M = 10” ”607-172-00-1 brodifakum (ISO); 4-hydroxi-3-[3-(4′-brom-4-bifenylyl)-1,2,3,4-tetrahydro-1-naftyl]kumarin 259-980-5 56073-10-0 Repr. 1A Acute Tox. 1 Acute Tox. 1 Acute Tox. 1 STOT RE 1 Aquatic Acute 1 Aquatic Chronic 1 H360D H330 H310 H300 H372 (blod) H400 H410 GHS08 GHS06 GHS09 Dgr (Fara) H360D H330 H310 H300 H372 (blod) H410 Repr. 1A; H360D: C ≥ 0,003 % STOT RE 1; H372 (blod): C ≥ 0,02 % STOT RE 2; H373 (blod): 0,002 % ≤ C < 0,02 % M = 10 M = 10” ”607-375-00-5 flokumafen (ISO); reaktionsmassa av cis-4-hydroxi-3-(1,2,3,4-tetrahydro-3-(4-(4-trifluormetylbensyloxi)fenyl)-1-naftyl)kumarin och trans-4-hydroxi-3-(1,2,3,4-tetrahydro-3-(4-(4-trifluormetylbensyloxi)fenyl)-1-naftyl)kumarin 421-960-0 90035-08-8 Repr. 1B Acute Tox. 1 Acute Tox. 1 Acute Tox. 1 STOT RE 1 Aquatic Acute 1 Aquatic Chronic 1 H360D H330 H310 H300 H372 (blod) H400 H410 GHS08 GHS06 GHS09 Dgr (Fara) H360D H330 H310 H300 H372 (blod) H410 Repr. 1B; H360D: C ≥ 0,003 % STOT RE 1; H372 (blod): C ≥ 0,05 % STOT RE 2; H373 (blod): 0,005 % ≤ C < 0,05 % M = 10 M = 10” ”607-623-00-2 diisobutylftalat 201-553-2 84-69-5 Repr. 1B H360Df GHS08 Dgr (Fara) H360Df” ”613-166-00-X flumioxazin (ISO); 2-[7-fluor-3-oxo-4-(prop-2-yn-1-yl)-3,4-dihydro-2H-1,4-bensoxazin-6-yl]-4,5,6,7-tetrahydro-1H-isoindol-1,3(2H)-dion — 103361-09-7 Repr. 1B Aquatic Acute 1 Aquatic Chronic 1 H360D H400 H410 GHS08 GHS09 Dgr (Fara) H360D H410 M = 1 000 M = 1 000 ” ”613-121-00-4 klorsulfuron (ISO); 2-klor-N-[[(4-metoxi-6-metyl-1,3,5-triazin-2-yl)amino]karbonyl]bensensulfonamid 265-268-5 64902-72-3 Aquatic Acute 1 Aquatic Chronic 1 H400 H410 GHS09 Wng (Varning) H410 M = 1 000 M = 100” ”616-011-00-4 N,N-dimetylacetamid 204-826-4 127-19-5 Repr. 1B Acute Tox. 4* Acute Tox. 4* H360D*** H332 H312 GHS08 GHS07 Dgr (Fara) H360D*** H332 H312” ”616-037-00-6 acetoklor (ISO); 2-klor-N-(etoximetyl)-N-(2-etyl-6-metylfenyl)acetamid 251-899-3 34256-82-1 Carc. 2 Repr. 2 Acute Tox. 4 STOT SE 3 STOT RE 2 Skin Irrit. 2 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 H351 H361f H332 H335 H373 (njure) H315 H317 H400 H410 GHS08 GHS07 GHS09 Wng (Varning) H351 H361f H332 H335 H373 (njure) H315 H317 H410 M = 1 000 M = 100” ”616-207-00-X polyhexametylenbiguanidhydroklorid PHMB — 32289-58-0 27083-27-8 Carc. 2 Acute Tox. 2 Acute Tox. 4 STOT RE 1 Eye Dam. 1 Skin Sens. 1B Aquatic Acute 1 Aquatic Chronic 1 H351 H330 H302 H372 (luftvägar) (inhalation) H318 H317 H400 H410 GHS08 GHS06 GHS05 GHS09 Dgr (Fara) H351 H330 H302 H372 (luftvägar) (inhalation) H318 H317 H410 M = 10 M = 10”